Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Zongertinib for Liver Disease
Recruiting1 awardPhase 1
San Antonio, Texas
This trial is open to adults aged 18-80 with a BMI between 18 and 42 kg/m\^2. Women who cannot get pregnant can participate. The study includes people with mild
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service